Ngyuen et al. [31] observed in cutaneous melanoma that the expression of DNMT3A increased as the pathological staging of the disease progressed and the hsa-miR-29c-5p expression decreased according to the stage of the disease. The gene discussed is DNMT3A; the disease is cutaneous melanoma.